Kura Oncology Inc’s recently made public that its Director Hasnain Faheem unloaded Company’s shares for reported $0.18 million on Mar 21 ’25. In the deal valued at $8.00 per share,22,682 shares were sold. As a result of this transaction, Hasnain Faheem now holds 23,983 shares worth roughly $0.17 million.
Then, FAHEEM HASNAIN bought 30,000 shares, generating $235,500 in total proceeds.
Before that, DOYLE THOMAS JAMES sold 4,949 shares. Kura Oncology Inc shares valued at $38,958 were divested by the SVP, Finance & Accounting at a price of $7.87 per share. As a result of the transaction, DOYLE THOMAS JAMES now holds 88,193 shares, worth roughly $0.63 million.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock fall -6.93% to $7.12. Over the last five days, the stock has lost -3.00%. Kura Oncology Inc shares have fallen nearly -18.25% since the year began. Nevertheless, the stocks have fallen -66.65% over the past one year. While a 52-week high of $23.48 was reached on 02/05/25, a 52-week low of $6.79 was recorded on 03/11/25. SMA at 50 days reached $7.81, while 200 days put it at $14.96.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 6.89, which if violated will result in even more drops to 6.66. On the upside, there is a resistance level at 7.54. A further resistance level may holdings at 7.96. The Relative Strength Index (RSI) on the 14-day chart is 40.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.60%. Stochastics %K at 59.73% indicates the stock is a holding.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2025-03-14, dropping by -0.23 million shares to a total of 9.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 9.25 million shares. There was a decline of -2.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
